Xanthine derivatives as antagonists at A1 and A2 adenosine receptors
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
A variety of alkylxanthines has been comparatively examined as antagonists of A1 adenosine receptors in rat fat cells, rat and bovine cerebral cortex and of A2 adenosine receptors in human platelets. With few exceptions all xanthine derivatives with 7-position substituents such as diprophylline, proxyfylline, pentoxifylline and etofylline were less potent antagonists than xanthine itself which had Ki-values of 170 mumol/l (A1) and 93 mumol/l (A2). Theophylline, caffeine and 3-isobutyl-1-methylxanthine were more potent than xanthine but nearly equipotent antagonists at both receptor subtypes. 8-Phenyl substituents considerably increased the antagonist potency at A1 and A2 receptors. 1,3-Diethyl-8-phenylxanthine was the most potent A2 antagonist (Ki 0.2 mumol/l) in human platelets. At A1 receptors 1,3-dipropyl-8-(2-amino-4-chlorophenyl)xanthine (PACPX) was the most potent antagonist in all three tissues with Ki-values from 0.3 to 8.6 nmol/l. Several 8-phenylxanthine derivatives were remarkably selective antagonists at A1 receptors. 8-Phenyltheophylline was approximately 700 times more potent as antagonist at A1 receptors (bovine brain) than at A2 receptors (human platelets), and PACPX was even 1,600 times more potent as A1 adenosine receptor antagonist. These compounds offer a possibility for a subtype-selective blockade of adenosine receptors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This mechanism promotes increased release of catecholamines from the adrenal medulla [ 6 ], stimulating glycogenolysis and lipolysis [ 6 , 7 ].”
From Involvement of Cardiorespiratory Capacity on the Acute Effects of Caffeine on Autonomic Recovery (2019) · cites this paper as [6]
In the citing paper
“Two suggested mechanisms for how CAF influences cardiovascular function include the activation of the sympathetic autonomic system through catecholamines released into the bloodstream [ 12 ] and the inhibition of adenosine receptors (A1, A2A, A2B) in the central nervous system [ 13 ].”
From Impact of Caffeine Intake Strategies on Heart Rate Variability during Post-Exercise Recovery: A Systematic Review and Meta-Analysis (2024) · cites this paper as [13]
In the citing paper
“Due to its structural similarity, caffeine can lead to the blockading of adenosine receptors (A1 and A2)4”
From Caffeine affects autonomic control of heart rate and blood pressure recovery after aerobic exercise in young adults: a crossover study (2017) · cites this paper as [4]
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Yung-Chi, C., & Prusoff, W. H. (1973) · Biochemical Pharmacology · doi:10.1016/0006-2952(73)90196-2 · Cited by 12,922
Metabolism of Isolated Fat Cells
Rodbell, M. (1964) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)51687-2 · Cited by 4,427
METABOLISM OF ISOLATED FAT CELLS. I. EFFECTS OF HORMONES ON GLUCOSE METABOLISM AND LIPOLYSIS.
Rodbell, M. (1964) · PubMed · Cited by 1,387
Subclasses of external adenosine receptors.
Londos, C., Cooper, D. M., & Wolff, J. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.5.2551 · Cited by 1,081
Adenosine receptors: targets for future drugs
Daly, J. W. (1982) · Journal of Medicinal Chemistry · doi:10.1021/jm00345a001 · Cited by 683
The enzymatic preparation of [α-32P]nucleoside triphosphates, cyclic [32P]AMP, and cyclic [32P]GMP
Walseth, T. F., & Johnson, R. A. (1979) · Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis · doi:10.1016/0005-2787(79)90122-9 · Cited by 573
Bruns, R. F., Daly, J. W., & Snyder, S. H. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.9.5547 · Cited by 548
Are Methylxanthine Effects Due to Antagonism of Endogenous Adenosine?
Fredholm, B. B. (1979) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(79)90046-4 · Cited by 409 · cited 1×
“For many years these compounds were believed to act via an inhibition of cyclic nucleotide phosphodiesterases, but now it has been recognized that theophylline and other xanthine derivatives have additional effects on adenosine receptors and are more potent as adenosine antagonists than as inhibitors of phosphodiester…”
BackgroundPREPARATION AND CHARACTERIZATION OF A PLASMA MEMBRANE FRACTION FROM ISOLATED FAT CELLS
McKeel, D. W., & Jarett, L. (1970) · The Journal of Cell Biology · doi:10.1083/jcb.44.2.417 · Cited by 400
Research works printed but not linked: 1
- Schwabe U (1985) Xanthine derivatives as antagonists at A1 and A2 adenosine receptors. Naunyn-Schmiedeberg's Arch Pharmacol Suppl 329: R37
Cited by
Polymorphism of human cytochrome P450 enzymes and its clinical impact
Zhou, S.-F., Liu, J.-P., & Chowbay, B. (2009) · Drug Metabolism Reviews · doi:10.1080/03602530902843483 · Cited by 826
“Theophylline Theophylline is a bronchidilator used in the treatment of asthma and chronic obstructive pulmonary disease (Barnes, 2005) and it acts by inhibition of the adenosine receptor (Marone et al., 1978; Schwabe et al., 1985).”
BackgroundAdenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential
Jacobson, K. A., Van Galen, P. J. M., & Williams, M. (1992) · Journal of Medicinal Chemistry · doi:10.1021/jm00081a001 · Cited by 456
Lohse, M. J., Klotz, K.-N., Lindenborn-Fotinos, J., Reddington, M., Schwabe, U., & Olsson, R. A. (1987) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/bf00165806 · Cited by 393
Self-citationBruns, R. F., Fergus, J. H., Badger, E. W., Bristol, J. A., Santay, L. A., Hartman, J. D., Hays, S. J., & Huang, C. C. (1987) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/bf00165037 · Cited by 371
Caffeine Use in Sports, Pharmacokinetics in Man, and Cellular Mechanisms of Action
Magkos, F., & Kavouras, S. A. (2005) · Critical Reviews in Food Science and Nutrition · doi:10.1080/1040-830491379245 · Cited by 344
Richardt, G., Waas, W., Kranzhöfer, R., Mayer, E., & Schömig, A. (1987) · Circulation Research · doi:10.1161/01.res.61.1.117 · Cited by 190
Monteiro, J., Alves, M., Oliveira, P., & Silva, B. (2016) · Molecules · doi:10.3390/molecules21080974 · Cited by 182
A binding site model and structure-activity relationships for the rat A3 adenosine receptor.
van Galen, P. J., van Bergen, A. H., Gallo-Rodriguez, C., Melman, N., Olah, M. E., IJzerman, A. P., Stiles, G. L., & Jacobson, K. A. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10559-2 · Cited by 178
Sympathomimetic effects of paraxanthine and caffeine in humans*
Benowitz, N. L., Jacob, P., Mayan, H., & Denaro, C. (1995) · Clinical Pharmacology & Therapeutics · doi:10.1016/0009-9236(95)90025-x · Cited by 165
Xanthine scaffold: scope and potential in drug development
Singh, N., Shreshtha, A. K., Thakur, M. S., & Patra, S. (2018) · Heliyon · doi:10.1016/j.heliyon.2018.e00829 · Cited by 152
“Therefore, in most cases bulkiness of N(7)-substituents considerably decreases the affinity [137, 164].”
BackgroundAdenosine A1 and A2 receptors: Structure–function relationships
van Galen, P. J. M., Stiles, G. L., Michaels, G., & Jacobson, K. A. (1992) · Medicinal Research Reviews · doi:10.1002/med.2610120502 · Cited by 129
Adenosine receptors and their modulators
Müller, C. E., & Scior, T. (1993) · Pharmaceutica Acta Helvetiae · doi:10.1016/0031-6865(93)90012-u · Cited by 126
Effect of adenosine receptor modulation on pentylenetetrazole‐induced seizures in rats
Katyal, J., & Gupta, Y. K. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0700869 · Cited by 114
Rathbone, M. P., Middlemiss, P. J., Kim, J.-K., Gysbers, J. W., Deforge, S., Smith, R. W. P., & Hughes, D. W. (1992) · Neuroscience Research · doi:10.1016/0168-0102(92)90030-g · Cited by 111
Peralta, C., Bulbena, O., Xaus, C., Prats, N., Cutrìn, J. C., Poli, G., Gelpı́, E., & Roselló‐Catafau, J. (2002) · Transplantation · doi:10.1097/00007890-200204270-00004 · Cited by 110
“This possibility cannot be discounted, because it has been reported that xanthine is also an inhibitor of adenosine receptors (24), and the protective role of adenosine receptor activation on hepatic I/R injury is FIGURE 5.”
BackgroundNicholson, C. D., Jackman, S. A., & Wilke, R. (1989) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1989.tb12029.x · Cited by 103
Olah, M. E., Jacobson, K. A., & Stiles, G. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31446-1 · Cited by 97
The cardiovascular effects of methylxanthines
Riksen, N. P., Smits, P., & Rongen, G. A. (2011) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-13443-2_16 · Cited by 65
Enoksson, S., Degerman, E., Toft, E., Large, V., & Arner, P. (1998) · Diabetologia · doi:10.1007/s001250050947 · Cited by 94
Pelleg, A., & Porter, R. S. (1990) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1990.tb02573.x · Cited by 88
Burdi, R., Rolland, J., Fraysse, B., Litvinova, K. S., Cozzoli, A., Giannuzzi, V., Liantonio, A., Camerino, G. M., Sblendorio, V. T., Capogrosso, R. F., et al. (2009) · Journal of Applied Physiology · doi:10.1152/japplphysiol.90985.2008 · Cited by 83
Ellis, J. L., & Farmer, S. G. (1989) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1989.tb11847.x · Cited by 83
Gonzaga, L. A., Vanderlei, L. C. M., Gomes, R. L., & Valenti, V. E. (2017) · Scientific Reports · doi:10.1038/s41598-017-14540-4 · Cited by 75
Characterization of vascular P2 purinoceptors in the rat isolated perfused kidney
Eltze, M., & Ullrich, B. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00244-0 · Cited by 79
Zheng, H., Crowley, J., Chan, J. C. K., Hoffmann, H., Hatherill, J. R., Ishizaka, A., & Raffin, T. A. (1990) · American Review of Respiratory Disease · doi:10.1164/ajrccm/142.5.1073 · Cited by 68
Ferkany, J. W., Valentine, H. L., Stone, G. A., & Williams, M. J. (1986) · Drug Development Research · doi:10.1002/ddr.430090202 · Cited by 65
Non-xanthine heterocycles: Activity as antagonists of A1 and A2-adenosine receptors
Daly, J. W., Hong, O., Padgett, W. L., Shamim, M. T., Jacobson, K. A., & Ukena, D. (1988) · Biochemical Pharmacology · doi:10.1016/0006-2952(88)90139-6 · Cited by 60
Self-citationAdenosine antagonists as potential therapeutic agents
Williams, M. J., & Jarvis, M. F. (1988) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(88)90182-7 · Cited by 59
Klotz, K., Vogt, H., & Tawfik-Schlieper, H. (1991) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00168610 · Cited by 59
“In particular, several 8-substituted methyl xanthines have been shown to exhibit marked differences in affinity for A 1 receptors from rat and bovine brain (Hamilton et al. 1985; Schwabe et al. 1985; Jacobson et al. 1986).”
BackgroundKim, J. ‐., Rathbone, M. P., Middlemiss, P. J., Smith, R. W. P., & Hughes, D. W. (1991) · Journal of Neuroscience Research · doi:10.1002/jnr.490280318 · Cited by 59
Stone, G. A., Jarvis, M. F., Sills, M. A., Weeks, B., Snowhill, E. W., & Williams, M. J. (1988) · Drug Development Research · doi:10.1002/ddr.430150104 · Cited by 59
Maemoto, T., Finlayson, K., Olverman, H. J., Akahane, A., Horton, R. W., & Butcher, S. P. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701465 · Cited by 57
Caffeine and the anticonvulsant potency of antiepileptic drugs: experimental and clinical data
Chrościńska–Krawczyk, M., Jargiełło-Baszak, M., Wałek, M., Tylus, B., & Czuczwar, S. J. (2011) · Pharmacological Reports · doi:10.1016/s1734-1140(11)70394-2 · Cited by 62
Anti-obesity potential of natural methylxanthines
Carrageta, D. F., Dias, T. R., Alves, M. G., Oliveira, P. F., Monteiro, M. P., & Silva, B. M. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2018.02.001 · Cited by 56
Farmer, S. G., Canning, B. J., & Wilkins, D. E. (1988) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1988.tb11655.x · Cited by 51
Evidence for an inhibitory A1 subtype adenosine receptor on pancreatic insulin-secreting cells
Hillaire‐Buys, D., Bertrand, G., Gross, R., & Loubatières-Mariani, M.-M. (1987) · European Journal of Pharmacology · doi:10.1016/0014-2999(87)90786-2 · Cited by 50
Hutchison, K. A., Nevins, B., Perini, F., & Fox, I. H. (1990) · Biochemistry · doi:10.1021/bi00473a020 · Cited by 50
Glomeruli and microvessels of the rabbit kidney contain both A1- and A2-adenosine receptors
Freissmuth, M., Hausleithner, V., Tuisl, E., Nanoff, C., & Sch�tz, W. (1987) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00165560 · Cited by 49
“Likewise, the antagonists theophylline and 8-phenyltheophylline compete for specific [t2sI]HPIA binding; the low potency of 8-phenyltheophylline is probably attributable to species differences, since the affinity of 8-phenylxanthines was found to vary considerably in different species (Murphy and Snyder 1982; Schwabe…”
BackgroundHutchison, K. A., & Fox, I. H. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)47195-0 · Cited by 49
Convulsant effects of some xanthine derivatives in genetically epilepsy-prone rats
Sarro, A. D., Grasso, S., Zappalà, M., Nava, F. A., & Sarro, G. D. (1997) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/pl00005027 · Cited by 47
Czuczwar, S. J., Ga̧sior, M., Janusz, W., Szczepanik, B., Wlodarczyk, D., & Kleinrok, Z. (1990) · Epilepsia · doi:10.1111/j.1528-1157.1990.tb05382.x · Cited by 47
Fredholm, B. B., Jonzon, B., & Lindstr�m, K. (1986) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00511409 · Cited by 47
“(Schwabe et al. 1985), suggesting that it cannot be regarded as a general A2-selective antagonist.”
Evidence for A1 and A2 adenosine receptors in guinea pig trachea
Ghai, G. R., Zimmerman, M. B., & Hopkins, M. F. (1987) · Life Sciences · doi:10.1016/0024-3205(87)90199-8 · Cited by 47
Inhibitory adenosine A1-receptors on rat locus coeruleus neurones
Regenold, J. T., & Illés, P. (1990) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00169735 · Cited by 46
Williams, M. J. (1989) · Medicinal Research Reviews · doi:10.1002/med.2610090205 · Cited by 41
Benjamim, C. J. R., Kliszczewicz, B., Garner, D. M., Cavalcante, T. C. F., da Silva, A. A. M., Santana, M. D. R., & Valenti, V. E. (2020) · Journal of the American College of Nutrition · doi:10.1080/07315724.2019.1705201 · Cited by 39
Illés, P., Rickman, H., Brod, I. I., Bucher, B., & Stoclet, J. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90316-6 · Cited by 40
Caffeine and the Kidney: What Evidence Right Now?
Bolignano, D., Coppolino, G., Barillà, A., Campo, S., Criseo, M., Tripodo, D., & Buemi, M. (2007) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2007.02.006 · Cited by 53
Chronic caffeine administration exacerbates renovascular, but not genetic, hypertension in rats.
Ohnishi, A., Branch, R. A., Jackson, K., Hamilton, R., Biaggioni, I., Deray, G., & Jackson, E. K. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112659 · Cited by 39
von der Leyen, H. E., Schmitz, W. L., Scholz, H., Scholz, J., Lohse, M. J., & Schwabe, U. (1989) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00168970 · Cited by 39
“1,3-diethyl-8-phenylxanthine (DPX) or theophylline are nonselective ( Schwabe et al. 1985 ).”
Self-citationSebastião, A. M., & Ribeiro, J. A. (1989) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1989.tb11802.x · Cited by 39
Single tonic–clonic seizure after energy drink abuse
Calabrò, R. S., Italiano, D., Gervasi, G., & Bramanti, P. (2012) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2011.12.010 · Cited by 38
“Although the precise molecular mechanism of the proconvulsant action of caffeine remains unclear, its psychoactive effect is probably due to the antagonizing effect on adenosine A1 and A2A receptors [14].”
BackgroundSzentmiklosi, A. J., Újfalusi, A., Cseppentö, A., Nosztray, K., Kovacs, P. L., & Szabó, J. (1995) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00169083 · Cited by 38
Lohse, M. J., Klotz, K., Diekmann, E., FRIEDRICH, K., & Schwabe, U. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90158-6 · Cited by 37
Self-citationKartı, Ö., Zengin, M. Ö., Kerci, S. G., Ayhan, Z., & Küsbeci, T. (2018) · Retina · doi:10.1097/iae.0000000000002058 · Cited by 38
Dual actions of adenosine on rat peritoneal mast cells
Lohse, M. J., Maurer, K., Gensheimer, H.-P., & Schwabe, U. (1987) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00169124 · Cited by 36
“As theophylline is considered as a non-selective antagonist at both Al,and Az receptors in every tissue examined so far ( Schwabe et al. 1985 ), this suggests that these effects of adenosine analogues are not mediated via classical adenosine receptors.”
BackgroundMethodSelf-citationMethylxanthine effects on caudate dopamine release as measured by electrochemistry
Morgan, M. E., & Vestal, R. E. (1989) · Life Sciences · doi:10.1016/0024-3205(89)90577-8 · Cited by 36
Mechanism for the emetic side effect of xanthine bronchodilators
Howell, R. E., Muehsam, W. T., & Kinnier, W. J. (1990) · Life Sciences · doi:10.1016/0024-3205(90)90123-9 · Cited by 32
Richardt, G. (1989) · Journal of Molecular and Cellular Cardiology · doi:10.1016/0022-2828(89)90742-6 · Cited by 32
Olivera, A., & López-Novoa, J. M. (1992) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1992.tb12748.x · Cited by 32
Effects of enprofylline on A1 and A2 adenosine receptors
Ukena, D., Schirren, C. G., & Schwabe, U. (1985) · European Journal of Pharmacology · doi:10.1016/0014-2999(85)90468-6 · Cited by 30
Self-citationCzuczwar, S. J., Jäckel, R., & Löscher, W. (1987) · Epilepsy Research · doi:10.1016/0920-1211(87)90030-1 · Cited by 30
Moraidis, I., & Bingmann, D. (1994) · Brain Research · doi:10.1016/0006-8993(94)91868-6 · Cited by 29
Satkunendrarajah, K., & Goshgarian, H. G. (2009) · Journal of Spinal Cord Medicine · doi:10.1080/10790268.2009.11760769 · Cited by 28
EVIDENCE FOR THE PRESENCE OF BOTH P1 AND P2 PURINOCEPTORS IN THE RAT MYOMETRIUM
Gillman, T. A., & Pennefather, J. N. (1998) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1998.tb02257.x · Cited by 29
van Galen, P. J. M., IJzerman, A. P., & Soudijn, W. (1990) · Nucleosides and Nucleotides · doi:10.1080/07328319008045138 · Cited by 28
Pharmacological profile of adenosine A2 receptor in PC12 cells
Noronha‐Blob, L., Marshall, R. P., Kinnier, W. J., & U'Prichard, D. C. (1986) · Life Sciences · doi:10.1016/0024-3205(86)90197-9 · Cited by 27
Adenosine Targeting as a New Strategy to Decrease Glioblastoma Aggressiveness
Bova, V., Filippone, A., Casili, G., Lanza, M., Campolo, M., Capra, A. P., Repici, A., Crupi, L., Motta, G., Colarossi, C., et al. (2022) · Cancers · doi:10.3390/cancers14164032 · Cited by 31
Influence of caffeine on blood pressure and platelet aggregation
Cavalcante, J. W. S., Santos, P. R. M., de Menezes, M. G. F., Marques, H. O., Cavalcante, L. P., & Pacheco, W. S. (2000) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2000000800002 · Cited by 26
Basal levels of adenosine modulate mGluR5 on rat hippocampal astrocytes
Cormier, R. J., Mennerick, S. J., Melbostad, H. S., & Zorumski, C. F. (2001) · Glia · doi:10.1002/1098-1136(20010101)33:1<24::aid-glia1003>3.0.co;2-l · Cited by 33
Siegmund, B., Welsch, J., Loher, F., Meinhardt, G., Emmerich, B., Endres, S., & Eigler, A. (2001) · Leukemia · doi:10.1038/sj.leu.2402232 · Cited by 25
Adenosine analogs inhibit fighting in isolated male mice
Palmour, R. M., Lipowski, C. J., Simon, C. K., & Ervin, F. R. (1989) · Life Sciences · doi:10.1016/0024-3205(89)90367-6 · Cited by 23
Illés, P., Jackisch, R., & Regenold, J. T. (1988) · The Journal of Physiology · doi:10.1113/jphysiol.1988.sp016985 · Cited by 23
Antagonism of adenosine receptors by caffeine and caffeine metabolites in equine forebrain tissues
Chou, C., & Vickroy, T. W. (2003) · American Journal of Veterinary Research · doi:10.2460/ajvr.2003.64.216 · Cited by 22
Chrościńska–Krawczyk, M., Ratnaraj, N., Patsalos, P. N., & Czuczwar, S. J. (2009) · Pharmacological Reports · doi:10.1016/s1734-1140(09)70137-9 · Cited by 22
Current Adenosinergic Therapies: What Do Cancer Cells Stand to Gain and Lose?
Kotulová, J., Hajdúch, M., & Džubák, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212569 · Cited by 23
“Noteworthy, pentoxifylline is also a xanthine derivative with non-specific antagonistic activity towards ARs [119].”
BackgroundOlah, M. E., Jacobson, K. A., & Stiles, G. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32411-0 · Cited by 21
Effects of Adenosine and its Analogues on Porcine Basilar Arteries: Are Only A 2 Receptors Involved?
McBean, D. E., Harper, A. M., & Rudolphi, K. A. (1988) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1988.6 · Cited by 21
Evidence for an A2 adenosine receptor in guinea pig lung
Ukena, D., Schirren, C. G., Klotz, K., & Schwabe, U. (1985) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00498856 · Cited by 21
“The half-maximally effective concentrations of the xanthine derivatives in guinea pig lung agree weil with those at A 2 receptors of human fibroblasts, rat hippocampus and human platelets (Bruns 1981; Fredholm and Persson 1982; Schwabe et al. 1985).”
Self-citationBier, D. D., Hartmann, R., & Holschbach, M. H. (2013) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.6520 · Cited by 20
Chrościńska–Krawczyk, M., Radzik, I., Miziak, B., & Czuczwar, S. J. (2014) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2014.920822 · Cited by 20
“No doubt, these data clearly indicate that coffee drinking results in pharmacologically relevant caffeine plasma concentration [9].”
BackgroundADENOSINE RECEPTOR AGONISTS AND ANTAGONISTS
Williams, M. J. (1991) · Elsevier eBooks · doi:10.1016/b978-0-12-672640-4.50013-3 · Cited by 20
Prodrugs for Masking the Bitter Taste of Drugs
Karaman, R. (2014) · InTech eBooks · doi:10.5772/58404 · Cited by 19
“It acts as an adenosine receptor antagonist and phosphodiesterase inhibitor [21].”
BackgroundPhosphodiesterase Type 4 Inhibitors: Potential in the Treatment of Multiple Sclerosis?
Dinter, H. (2000) · BioDrugs · doi:10.2165/00063030-200013020-00002 · Cited by 22
“In addition, as a methylxanthine derivative, pentoxifylline not only inhibits various PDEs[73] but is also an antagonist of adenosine A1 and A2 receptors,[74] and may depress brain adrenoreceptor sites acutely.”
BackgroundWłaź, P., Rolinski, Z., Kleinrok, Z., & Czuczwar, S. J. (1992) · Journal of Neural Transmission · doi:10.1007/bf01245350 · Cited by 19
“Generally, methylxanthines (theophylline, caffeine, pentoxifylline) are regarded as adenosine receptor antagonists (Schwabe et al., 1985) and possess a clearcut convulsive potential in experimental animals (Ault et al., 1987; Chu, 1981; Czuczwar et al., 1987 a, 1990 a) and both aminophylline and…”
BackgroundThe Effect of Theophylline on Regional Cerebral Blood Flow Responses to Hypoxia in Newborn Piglets
McPhee, A. J., & Maxwell, G. M. (1987) · Pediatric Research · doi:10.1203/00006450-198706000-00014 · Cited by 19
Classification and Characterization of Purinoceptors
Burnstock, G. (1990) · Springer eBooks · doi:10.1007/978-1-4612-3400-5_36 · Cited by 19
Selective activity of bamifylline on adenosine A1-receptors in rat brain
Abbracchio, M. P., & Cattabeni, F. (1987) · Pharmacological Research Communications · doi:10.1016/0031-6989(87)90091-9 · Cited by 18
Inhibition by adenosine of histamine and leukotriene release from human basophils
Peachell, P. T., Lichtenstein, L. M., & Schleimer, R. P. (1989) · Biochemical Pharmacology · doi:10.1016/0006-2952(89)90404-8 · Cited by 18
Sampaio-Jorge, F., Morales, A. P., Pereira, R., Barth, T., & Ribeiro, B. G. (2021) · Scientific Reports · doi:10.1038/s41598-021-03158-2 · Cited by 15
Czuczwar, S. J., Janusz, W., Szczepanik, B., & Kleinrok, Z. (1991) · Journal of Neural Transmission · doi:10.1007/bf01250573 · Cited by 16
“theophyl l ine or caffeine) which are effective adenos ine antagonis ts (Schwabe et al., 1985), possess convuls ive potent ia l per se (Chu, 1981; Czuczwar et al.”
BackgroundCarney, J. M., Cao, W., Logan, L., Rennert, O. M., & Seale, T. W. (1986) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(86)90385-0 · Cited by 16
Conlay, L. A., Evoniuk, G. E., & Wurtman, R. J. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.12.4483 · Cited by 15
Thebromine Targets Adenosine Receptors to Control Hippocampal Neuronal Function and Damage
Valada, P., Alçada-Morais, S., Cunha, R. A., & Lopes, J. P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810510 · Cited by 18
Effect of adenosine receptor agonists and antagonists on morphine-induced catalepsy in mice
Zarrindast, M., Iraie, F., Heidari, M.-R., & Mohagheghi-Badi, M. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01221-1 · Cited by 15
Involvement of Cardiorespiratory Capacity on the Acute Effects of Caffeine on Autonomic Recovery
Gonzaga, L. A., Vanderlei, L. C. M., Gomes, R. L., Garner, D. M., & Valenti, V. E. (2019) · Medicina · doi:10.3390/medicina55050196 · Cited by 13
“This mechanism promotes increased release of catecholamines from the adrenal medulla [6], stimulating glycogenolysis and lipolysis [6,7].”
BackgroundAsztalos, Z., Lossos, M., & Friedrich, P. (1991) · Behavior Genetics · doi:10.1007/bf01066727 · Cited by 14
Mechanisms underlying the supra-maximal thermogenesis elicited by aminophylline in rats
WANG, L. C. H., Jourdan, M. L., & Lee, T. F. (1989) · Life Sciences · doi:10.1016/0024-3205(89)90491-8 · Cited by 14
Radioligand Binding Assays for Adenosine Receptors
Williams, M. J., & Jacobson, K. A. (1990) · Humana Press eBooks · doi:10.1007/978-1-4612-4504-9_2 · Cited by 13
8‐phenyltheophylline as an inhibitor of cyclic AMP hydrolysis by cyclic nucleotide phosphodiesterase
Nicholson, C. D., & Wilke, R. (1989) · Journal of Autonomic Pharmacology · doi:10.1111/j.1474-8673.1989.tb00207.x · Cited by 13
Metadata
- Authors
- Schwabe, U., Ukena, D., & Lohse, M. J.
- Affiliations
- Heidelberg University (DE)
- ORCID
- Lohse, M. J.
- Venue
- Naunyn-Schmiedeberg's Archives of Pharmacology
- Published
- 1985-09
- Volume
- 330
- Issue
- 3
- Pages
- 212-221
- ISSN
- 0028-1298 (ISSN-L)
- 1432-1912
- OpenAlex
- W2015172541
- Cited by
- 153
- References
- 34
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 1 · 2023: 2 · 2022: 5 · 2021: 4 · 2020: 1 · 2019: 3 · 2018: 3 · 2017: 1 · 2016: 1 · 2014: 2 · 2013: 1 · 2012: 2
- FWCI
- 5.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Naunyn-Schmiedeberg s Archives of Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
- Keywords
- xanthine derivatives, adenosine A1 receptor, adenosine A2 receptor, adenosine receptor antagonists, 8-phenyltheophylline, theophylline, caffeine, 3-isobutyl-1-methylxanthine, diprophylline, pentoxifylline, receptor subtype selectivity, human platelets, cerebral cortex, adipocytes
- MeSH terms
- Adenosine, Adenosine Diphosphate, Adenylyl Cyclases, Adipose Tissue, Animals, Blood Platelets, Brain Chemistry, Cattle, Cell Membrane, Humans, Male, Rats, Inbred Strains, Receptors, Cell Surface, Receptors, Purinergic, Xanthines, Adenosine-5'-(N-ethylcarboxamide), Rats, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.